ASHLEY HUNDELT: Open Payments
NPI 1740720143 · COULTERVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,209 in 68 payments from 10 companies in 2025. Trend: 2023 $905 · 2024 $546 · 2025 $1,209
Food & beverage: $1,209
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 21 | $353 |
| ABBVIE INC. | 21 | $326 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $268 |
| Vanda Pharmaceuticals Inc. | 2 | $56 |
| Janssen Pharmaceuticals, Inc | 2 | $43 |
| Axsome Therapeutics, Inc. | 2 | $40 |
| Collegium Pharmaceutical, Inc. | 2 | $35 |
| Alkermes, Inc. | 2 | $35 |
| E.R. Squibb & Sons, L.L.C. | 1 | $33 |
| Lundbeck LLC | 1 | $21 |
Products named: Qelbree, VRAYLAR, CAPLYTA, FANAPT, Auvelity, Jornay PM, ARISTADA, COBENFY.
Industry payments across IL — which companies pay providers there.
